SavedAdd your journal

Journals / Damar Cerrahi Dergisi / 2016 / Cilt: 25 - Sayı: 3

Implantable Cardiac Electronic Devices: Retrospective Analysis of Early Complications in Patients with Axillary Vein Puncture

İmplante Edilebilen Kardiyak Elektronik Cihazlar: Aksiller Girişim Yapılan Hastalarda Erken Dönem Komplikasyonların Geriye Dönük Analizi

Yalçın GÖKOĞLAN
Emin İNCE
Pages
117–121
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were no peri--procedural fatal complication.Conclusion: Results of our study demonstrates that, ICED implantation via axillary route is safe and feasible.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Implantable Cardiac Electronic Devices (ICED) are known to improve qual--ity of life and prolong survival in selected patients.
📊
Key Findings & Data:The aim of this study is to investigate early complication rates after ICED implantation.
💡
Conclusion & Impact:There were no peri--procedural fatal complication.Conclusion: Results of our study demonstrates that, ICED implantation via axillary route is safe and feasible.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Implantable Cardiac Electronic Devices (ICED) are known to improve qual--ity of life and prolong survival in selected patients. The aim of this study is to investigate early complication rates after ICED implantation. Material and Methods: We retrospectively analyzed ICEDprocedures via axillary vein route in 196 patients between 2014 and 2016. Complications in the perioperative period and month follow-up were recorded. Results: 145 male (74%) and 51 female(26%) patients were enrolled in the study. The mean age of the patients was 66.4:129 (20--92) years.We observed five early period complications. There were no peri--procedural fatal complication.Conclusion: Results of our study demonstrates that, ICED implantation via axillary route is safe and feasible.

Özet

Amaç: İmplante edilebilen kardiyak elektronik cihazların (İEKEC), seçilmiş hastalarda yaşamkalitesini ve beklentisini artırdığı bilinmektedir. Bu çalışmanın amacı, İEKEC takılmasına bağlı olu--şan erken dönem komplikasyonları araştırmaktır. Gereç ve Yöntemler: 2014 ile 2016 yıllan ara--sında aksiller girişim ile İEKEC takılmış 196 hastayı retrospektif olarak inceledik. Perioperatifdönemde ve birinci ay kontrolündeki komplikasyonlar kaydedildi. Bulgular: Çalışmaya dahil edi--len hastaların 145'i erkek (%74), 51'i kadındı (%26). Ortalama hasta yaşı 66.4i12,9 (20-92) idi. Beşhastada erken dönem komplikasyonu saptadık. İşleme bağlı herhangi bir fatal komplikasyon ol--madı. Sonuç: Çalışmamızın sonuçları, aksiller venöz yolla İEKEC implantasyonunun güvenli ve uy-gulanabilir olduğunu göstermektedir.

🔖

Cite This Article

GÖKOĞLAN, Y., İNCE, E. (2022). Implantable Cardiac Electronic Devices: Retrospective Analysis of Early Complications in Patients with Axillary Vein Puncture. Damar Cerrahi Dergisi, Cilt: 25 - Sayı: 3, 117–121. https://ajindex.com/articles/486666

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Mond HG, Irwin M, Ector H, Proclemer A. The 6. Belott P. How to access the axillary vein. Heart 13. Lekkerkerker JC, van Nieuwkoop C, Trines SA, world survey of cardiac pacing and cardioverter- Rhythm 2006
  2. van der Bom JG, Bernards A, van de Velde ET, et defibrillators: calendar year 2005 an International 7_ Liu P, Zhou YF, Yang P, Gao YS, Zhao GR, Ren al. Risk factors and time delay associated with Cardiac Pacing and Electrophysiology Society SY, etal. Optimized Axillary Vein Technique ver- cardiac device infections: Leiden device registry. ('CPFS) proiect. Pacing C"" Electrophysıol sus Subclavian Vein Technique in Cardiovascu- Heart 2009?95(9):715'20' 2008'31(9)'1202'2' lar Implantable Electronic Device Implantation: 14. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Epstein AE! DiMarco JP: EIIenbogen KAI ESİGS NA Randomized Controlled Study. Chin edJ (Engl) Hayes DL, Wilson WR, etal. Risk factor analysis 3", Freedman RA, Gettes LS, et al. 2012 2016
  3. 129(22): 2647-51. of permanent pacemaker infection. Clin Infect Dis ACCF/AHA/HRS focused update i9°°rp°rated int" 8. Yildirim v, Doganci s, Ince E, Ozkan G, Kadan M, 200745311664 73- the ACCF/AHA/HRS 2008 guıdelınes for deVice- based therapy of cardiac rhythm abnormalities: Kaya E, et al'. Totally ımplantable central venous 15. Darouıche R0, Wall MJ Jr, Itanı KM, Otterson report of the American College of Cardiology ou n- access ports. Retrospective Analysıs Of Complı- MF, Webb AL, Carrıck MM, et aI. Chlorhexıdınedation/American Heart Association Task Force on cations And Pitfalls. Kasmera 2015
  4. 43(2):92-112. alcohol versus powdone-iodine for surgical-Site Practice guidelines and the heart rhythm society.J 9. Fyke F- Doppler guided extrathoracic introducer antısepsıs. Engl Med 2010
  5. 362(1):"- Am Coll Cardiol 2013
  6. 61(3):e6-75. insertion. Pacing Clin Electrophysiol 1995
  7. Tobin K, Stewart J,WestveerD, Frumin H. Acute 1017-21. 16. Alter P, Waldhans S, Plachta E, Moosdorl R, complications of permanent pacemakerimplanta- 10. TakahashiT, Bhandari AK, WatanukiM,Cannom Grımm W' Complıcatıons of implantable cartion: Theirfinancial implication and relation to vol- DS, Sakurada H, Hiraoka M. High incidence of de- dıoverter defıbrıllator therapy '" 440 G?nsecul've ume and operator experience. Am Cardiol vice-related and lead-related complications in the patients. Pacıng C"" Electrophysıol 2005? 2000
  8. 6, A9. dual-chamber implantable cardioverter defibrillator 28l9):926'32' Ellenbogen KA, Hellkamp AS, Wilk